Melbourne/Malawi collaboration to explore using new on-the-spot syphilis diagnosis tool for at-risk mothers in Africa
Posted: 15 January 2025 A team from the University of Melbourne will travel to Malawi next year to work with colleagues from the Kamuzu University of Health Sciences (KUHeS) to field test and work towards implementation of a…
Australia’s first mRNA vaccine candidate addresses COVID ‘immune imprinting’
Posted: 15 January 2025 The team of scientists behind Australia’s first mRNA COVID-19 vaccine have published a new study demonstrating the vaccine’s ability to overcome the issue of ‘immune imprinting.’ Immune imprinting occurs when exposure to one virus…
Shaping The Future Of Our Medical Research Workforce
Posted: 15 January 2025 The Allan Labor Government is supporting the state’s medical researchers to drive the next generation of medical breakthroughs with a new Workforce Action Plan. Minister for Medical Research Ben Carroll this week launched Victoria’s Health and Medical…
Completion of Genetype Risk Assessment Portfolio Acquisition
Posted: 15 January 2025 Transformative, predictive cancer diagnostics technology company, Rhythm Biosciences Ltd (ASX: RHY) (Rhythm or the Company) advises that it has completed the acquisition of select Australian and US assets related to the Genetype Business from…
Patient enrolment completed for INSIGHT-003
Posted: 15 January 2025 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer andautoimmune disease, today announces that patient enrolment has been completed in the investigatorinitiated INSIGHT-003…
Cartherics raises over $15 Million in oversubscribed private financing round to advance cell therapy programs
Posted: 19 December 2024 Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer and other diseases, is pleased to announce that it has successfully raised well over its target AU$15M…
Doherty Institute and the University of Calgary partner to award AU$175,000 in grant funding
Posted: 19 December 2024 Developing advanced rapid diagnostics for the mpox virus and consolidating global expertise in human organoids to aid pandemic therapeutic research are just two of the innovative projects being funded through the Melbourne-Calgary Collaborative Seed…
Starpharma receives positive feedback from FDA on DEP® SN38 clinical pathway for platinum-resistant ovarian cancer
Posted: 19 December 2024 Starpharma (ASX: SPL, US OTC: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today announces a positive development regarding its DEP® SN38 (DEP®…
Stem Cells: Hope on the Horizon for Preterm Babies
Posted: 18 December 2024 Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children’s Hospital have successfully collected and reinfused umbilical cord blood cells in extremely premature babies, offering…
Cartherics awarded US$300K G-Rex Grant to accelerate clincial manufacturing of CAR-NK cell therapy
Posted: 18 December 2024 Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, is pleased to announce that it has been awarded a US$300K G-Rex grant to…
4DMedical wins contract to supply lung imaging technology to US radiology company
Posted: 17 December 2024 4DMedical (ASX: 4DX) has been awarded a contract with US-based Imaging Partners of Orange County (IPOC) to provide computed tomography (CT) scans for lung ventilation (LVAS) and lung density (LDAf) analysis. The contract – the…
Weaponising exosomes for breast cancer treatment
Posted: 17 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-ofconcept (POC) study,…
